As of market close today there is nothing to worry about and nothing required by those long on Thrm .....except a little patience. It seems impossible now to imagine a scenario that will reward investors with anything but a significantly positive return.
The following is a summary of a review I did this afternoon of the HC site.
* 117 tests are currently under HC review
* Of those, 20 are considered rapid (hours instead of days)
* Of those, only 8 are POC ....and ALL require either a blood or nasopharyngeal swab sample and a
health care professional to carry out the test.
There is NOTHING in the descriptions of these tests that would suggest they could be used on the massive scale governments require.
There is one, but is not quite ready for review .....CoviSafe. For you bashers and naysers this is not a pump .....follow the NRs, do your own review of the HC site and read the dozens of articles referring to the need ....all over the world. There is no other reasonable conclusion.
On the Frankfurt Exchange, Thrm finished at $.695 CAD, the OTC $.65 CAD
Morningstar's Fair Value so after market close yesterday was $1.01 and their speculative 1-star valuation, $10.57.